Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine. - Janes H; Fong Y; Huang Y; Benkeser D; Kelly EJ; Hirsch I; Stanley AM; Villafana T; Petropoulos CJ; Leith A; Haugaard D; Webb B; et al. (NPJ vaccines, 2026)